Rocket


Overview
Financials
News + Filings
Key Docs
Ownership


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
BeyondSpring Inc. (BYSI) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"BeyondSpring Inc."
07/14/2023 6-K Quarterly results
05/12/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K"
04/18/2023 6-K Quarterly results
04/18/2023 20-F Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
03/14/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K"
02/28/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "FORM 6-K"
02/24/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K"
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/09/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"BeyondSpring Inc."
12/30/2022 6-K Quarterly results
11/23/2022 6-K Quarterly results
08/29/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K"
06/13/2022 6-K Quarterly results
06/09/2022 6-K Quarterly results
04/22/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K"
04/14/2022 20-F Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
02/14/2022 SC 13G/A ALLIANCEBERNSTEIN L.P. reports a
02/14/2022 SC 13G Decheng Capital Management III , LLC reports a 12.7% stake in BeyondSpring Inc.
02/14/2022 SC 13G/A Shenzhen Sangel Capital Management Ltd Co reports a 3.2% stake in BeyondSpring Inc.
02/11/2022 SC 13G/A Ever Regal Group Ltd reports a 26.5% stake in BeyondSpring Inc.
01/11/2022 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Press Release"
12/30/2021 6-K Quarterly results
Docs: "FORM 6-K",
"BeyondSpring Announces Third Quarter 2021 Financial Results and Provides a Corporate Update"
12/27/2021 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K"
12/01/2021 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"BeyondSpring Pharmaceuticals Receives Complete Response Letter from the FDA for Plinabulin New Drug Application for Prevention of Chemotherapy-Induced Neutropenia"
11/10/2021 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"BeyondSpring Appoints Commercial Leader Mark Santos to its Board of Directors"
09/21/2021 6-K Quarterly results
09/10/2021 6-K Quarterly results
08/26/2021 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"BeyondSpring Announces Exclusive Commercialization and Co-development Agreement with Jiangsu Hengrui Pharmaceuticals for Plinabulin in Greater China"
08/05/2021 6-K Quarterly results
08/04/2021 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"BeyondSpring Announces Positive Topline Results from"
07/14/2021 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"BeyondSpring Strengthens Board with the Addition of Ex-Immunomedics and Constellation Commercial Head Brendan Delaney"
07/14/2021 EFFECT Form EFFECT - Notice of Effectiveness:
06/16/2021 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"NEW YORK, Jun. 16, 2021 – BeyondSpring Inc."
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy